NUP160 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.451240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.591760E-01
Normal-vs-Stage2
1.818610E-01
Normal-vs-Stage3
1.719410E-01
Normal-vs-Stage4
7.900800E-01
Stage1-vs-Stage2
6.034400E-01
Stage1-vs-Stage3
1.111790E-01
Stage1-vs-Stage4
2.022400E-01
Stage2-vs-Stage3
9.145700E-02
Stage2-vs-Stage4
2.953800E-01
Stage3-vs-Stage4
4.818400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.439390E-01
Normal-vs-AfricanAmerican
5.538400E-01
Normal-vs-Asian
6.875500E-02
Caucasian-vs-AfricanAmerican
3.651800E-01
Caucasian-vs-Asian
1.996830E-01
AfricanAmerican-vs-Asian
1.141010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.539390E-01
Normal-vs-Female
1.556040E-01
Male-vs-Female
6.327200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.572400E-01
Normal-vs-Age(41-60Yrs)
3.303600E-01
Normal-vs-Age(61-80Yrs)
1.153380E-01
Normal-vs-Age(81-100Yrs)
6.947600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.422000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.727800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.479200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.453800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.844300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.021600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.418200E-02
Normal-vs-Daily Drinker
7.604300E-02
Normal-vs-Weekly Drinker
1.667610E-01
Normal-vs-Occasional Drinker
4.509200E-01
Normal-vs-Social Drinker
5.411000E-01
Non Drinker-vs-Daily Drinker
6.945800E-01
Non Drinker-vs-Weekly Drinker
6.220000E-01
Non Drinker-vs-Occasional Drinker
1.311020E-01
Non Drinker-vs-Social Drinker
1.514850E-01
Daily Drinker-vs-Weekly Drinker
5.161600E-01
Daily Drinker-vs-Occasional Drinker
1.021820E-01
Daily Drinker-vs-Social Drinker
1.003040E-01
Weekly Drinker-vs-Occasional Drinker
3.695600E-01
Weekly Drinker-vs-Social Drinker
3.404200E-01
Occasional Drinker-vs-Social Drinker
8.906600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.528400E-01
Normal-vs-Grade 2
1.042370E-01
Normal-vs-Grade 3
1.166410E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.037500E-02
Grade 1-vs-Grade 3
2.825900E-02
Grade 1-vs-Grade 4
3.528400E-01
Grade 2-vs-Grade 3
2.198000E-01
Grade 2-vs-Grade 4
1.042370E-01
Grade 3-vs-Grade 4
1.166410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.511410E-01
Normal-vs-NonDiabetic
9.099600E-02
Diabetic-vs-NonDiabetic
8.133400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.798300E-02
Normal-vs-NoPancreatitis
1.185790E-01
Pancreatitis-vs-NoPancreatitis
7.179400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.877830E-01
Normal-vs-N1
1.532830E-01
N0-vs-N1
5.768000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.825400E-01
Normal-vs-TP53-NonMutant
2.136400E-01
TP53-Mutant-vs-TP53-NonMutant
1.190760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
